New custom-designed treatment option for high-risk aortic aneurysms
Source: MedicalXpress
Vascular surgeons at NewYork-Presbyterian/Weill Cornell Medical Center are investigating the use of custom-designed stent grafts for the treatment of thoracoabdominal aortic aneurysms—a potentially deadly enlargement of the main artery carrying blood from the heart to the body and vital organs—for patients deemed high risk for open surgery. The FDA-approved clinical trial aims to address the unmet need for minimally invasive stent graft devices that can provide a safe and effective treatment for patients with aneurysms located in the aorta in both the chest and abdomen. No stent graft treatment is currently commercially available for these patients.
Survival after ruptured abdominal aortic aneurysm significantly lower in England than USA
Source: MedicalXpress
The care given to patients after ruptured abdominal aortic aneurysm (rAAA) in the US outstrips that in English NHS hospitals, according to a major new study published as part of a special issue of The Lancet ahead of the American College of Cardiology’s 63rd Annual Scientific Session. It shows that the chance of surviving a hospital stay for a rAAA is significantly higher in the USA than in England.
Analysts forecast Global Endovascular Abdominal Aortic Aneurysm Repair Devices market to grow at CAGR of 10.67%
Source: NewsMedical
The analysts forecast the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market to grow at a CAGR of 10.67 percent over the period 201-2016. One of the key factors contributing to this market growth is the high prevalence of abdominal aortic aneurysms. The Global Endovascular Abdominal Aortic Aneurysm Repair Devices market has also been witnessing the increasing demand for minimally invasive surgeries. However, the risk of complications and re-interventions associated with endovascular abdominal aortic aneurysm repair procedures could pose a challenge to the growth of this market.
Short-term Inactivity Impairs Vascular Function
Source: Department of Surgery, Division of Vascular Surgery – March 25, 2014
A clinical study led by the Grenon Lab at UCSF (Division of Vascular Surgery) looked at the effects of physical inactivity on vascular endothelial function and arterial stiffness, two measures that relate to cardiovascular risk. Their results showed that a short term exposure to physical inactivity leads to quantifiable impairment in endothelial function, artery wall stiffness and diastolic blood pressure.
The group hypothesized that this may be associated with a vascular deconditioning state. These findings have the potential for widespread relevance: in hospitalized and post-operative patients, whose physical activity is limited and their vascular healing may be compromised as a result, and among the general population because physical activity levels are consistently declining. A paper detailing the findings was presented in February at the annual Academic Surgical Congress and and published in the “Journal of Surgical Research”.
Depression is a risk factor for people with peripheral arterial disease
Source: dailyRx
Which comes first? Poor vascular health or depression? It appears that depression is tightly linked to the health of the blood vessels and onset comes along with risk factors from peripheral artery disease (PAD).
A new study finds that depression is common in patients with PAD, a circulation issue. These results suggest that a healthier lifestyle could then improve both conditions.
Vascular surgery patients more likely to quit smoking with doctor counseling
Source: dailyRx
Doctors don’t give advice for fun—they give it for the patient’s health. So when a doctor advises a patient to quit smoking, it’s to help save his or her life.
A recent study asked vascular surgery patients if they quit smoking after surgery. Researchers found that those patients who were either counseled by their doctors to quit, given smoking cessation medication or referred to a smoking cessation specialist were nearly 50 percent more successful at quitting than patients who were told nothing.
We’ve Moved! Nashville Vascular and Vein Institute is now located at 330 23rd Avenue North, Suite 100, Nashville, TN 37203. We will see you at our new office location beginning Wednesday, August 27th! Our new office hours are: 8:00AM-4:30PM Monday-Friday.